23Jul 2023
Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial

Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial

This study compared Fakhravac and BBIBP-Corv2 vaccines in a phase III trial. This study enrolled 24,056 adults in four groups. All observed local and systemic adverse reactions were generally self-limited and resolved completely. Fakhravac inactivated SARS-CoV-2 vaccine has comparable safety and efficacy to the BBIBP-Corv2 vaccine.

  • #family health

Like

Save

Share